Active Ingredient (In Each Tablet)
Meclizine HCl 25 mg
Bonine Tablet, Chewable
FDA Label NDC 65197-296
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Wellspring Pharmaceutical Corporation for the product Bonine (NDC 65197-296). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, directions, other information, inactive ingredients, questions?, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Antiemetic
Uses
prevents and treats nausea, vomiting or dizziness associated with motion sickness
Directions
- dosage should be taken one hour before travel starts
- adults and children 12 years of age and over: take 1 to 2 tablets once daily or as directed by a doctor
Other Information
store at room temperature 20°– 25°C (68°–77°F)
Inactive Ingredients
croscarmellose sodium, crospovidone, FD&C red #40 lake, lactose, magnesium stearate, raspberry flavor, silica, sodium saccharin, stearic acid, vanilla flavor.
Questions?
call toll-free 1 (844) 241-5454 or visit us on the web at www.bonine.com
* Please review the disclaimer below.
